Aspira Pathlab opened lower at ₹116.05, compared with its previous close of ₹120.65. In the last trading session on 12 Nov 2026, the stock traded between ₹114.65 and ₹126.45, with an average traded price of ₹122.28. It showed an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Aspira Pathlab is now worth
₹ 10,693.00
Giving a profit of
₹ 693.00 (6.93%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+5.80 (+4.81%)
Day High
₹126.45
Day Low
₹114.65
Day Open
₹116.05
Prev Close
₹120.65
Volume
1,562
Value Traded
₹0.02 Cr
1W Return
-9.90%
1M Return
9.96%
3M Return
23.07%
6M Return
98.23%
1Y Return
108.08%
Market Cap (₹ Cr.)
130
PE Ratio
-36.00
PB Ratio
11.25
Dividend Yield
-
ROE
16.62%
ROCE
15.71%
Book Value (₹)
10.72
Face Value (₹)
10.00
EPS (TTM)
0.41
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-9.90%
6 Weeks
-
1 Month
9.96%
3 Months
23.07%
9 Months
96.38%
Aspira Pathlab Q2FY27 Results: Net loss widens to ₹115.95 lakh, revenue down 22.6%
Net loss widened to ₹115.95 lakh in Q2FY27 from a profit of ₹183.54 lakh in Q2FY26. Revenue from operations declined 22.6% YoY to ₹626.04 lakh. Employee benefits expense rose sharply to ₹298.22 lakh from ₹214.63 lakh in the previous year. Auditor highlighted contingent liabilities of ₹111.50 lakh related to lease termination suits.
6 days agoAspira Pathlab promoter Jay Arvind Bhanushali buys 245 more shares
Jay Arvind Bhanushali acquired 245 equity shares on September 28, 2026. Total holding rises to 7,49,507 shares, maintaining a 7.28% stake. Transaction conducted via open market and disclosed to BSE on September 30, 2026.
1mo agoAspira Pathlab net profit falls to ₹5.13 lakh in FY26
Net profit declined to ₹5.13 lakh in FY26 from ₹207.26 lakh in FY25. 53rd AGM held virtually on September 25, 2026, with 28 attendees. Shareholders approved re-designation of Nikunj Velji Mange as Managing Director. Material related party transaction with Yashraj Research Foundation approved.
1mo agoAspira Pathlab promoter Jay Arvind Bhanushali buys 1,387 shares
Jay Arvind Bhanushali acquired 1,387 shares via open market. Promoter's stake rose to 7.27% from 7.25%. Total holding stands at 7,47,838 shares. No shares are pledged or encumbered.
1mo agoAspira Pathlab board approves ₹65 crore right issue
Aspira Pathlab board approves right issue of up to ₹65 crore. Funds to be raised via equity or convertible instruments. Issue subject to shareholder and regulatory approvals. Right Issue Committee formed to finalize terms and record date.
2mo agoAspira Pathlab promoter Jay Arvind Bhanushali acquires 74 shares
Promoter Jay Arvind Bhanushali acquired 74 equity shares in Aspira Pathlab via open market on September 10, 2026. The acquisition leaves his total stake unchanged at 7.25% of the voting capital. His total holding increased from 7,46,377 to 7,46,451 shares. The disclosure was filed with the BSE on September 11, 2026, under SEBI SAST Regulations.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹8,589.00 | +0.87% | ₹1,23,496.64 | 52.40 | +14.55% | |
| ₹946.00 | -0.03% | ₹92,075.15 | 66.60 | -14.28% | |
| ₹685.90 | +1.39% | ₹90,221.72 | 98.20 | +16.25% | |
| ₹720.10 | -2.15% | ₹62,769.13 | 113.80 | +5.69% | |
| ₹763.10 | +0.41% | ₹57,610.86 | 54.00 | -21.28% | |
| ₹1,447.20 | +0.52% | ₹38,911.12 | 63.10 | +23.29% | |
| ₹1,859.10 | +1.03% | ₹37,992.72 | 43.70 | +5.68% | |
| ₹1,981.50 | -1.36% | ₹33,259.24 | 57.30 | +28.64% | |
| ₹729.85 | +0.35% | ₹30,654.17 | 155.10 | +6.18% | |
| ₹446.95 | -0.19% | ₹18,041.99 | 97.10 | -32.67% | |
| ₹554.00 | +0.50% | ₹17,563.25 | 85.10 | +8.39% | |
| ₹670.00 | +0.59% | ₹16,144.77 | 39.00 | +31.68% |
An investment of ₹10,000 made 5 years ago in Aspira Pathlab is now worth
₹ 10,693.00
Giving a profit of
₹ 693.00 (6.93%)
Note: Past profits do not guarantee future returns.
